MediciNova

-$0.01 (-0.45%) Today
-$0.03 (-1.36%) As of 1:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MediciNova and other ETFs, options, and stocks.

About MNOV

MediciNova, Inc. is a biopharmaceutical company, which engages in the acquisition and development of small molecule therapeutics for the treatment of diseases with unmet medical needs. Its development pipeline consists of clinical-stage compounds for the treatment of acute exacerbations of asthma and COPD, progressive multiple sclerosis, methamphetamine addiction, neuropathic pain, asthma, interstitial cystitis, and solid tumor cancers.

CEO
Yuichi Iwaki
Employees
9
Headquarters
La Jolla, California
Founded
2000

MNOV Key Statistics

Market cap
108.39M
Price-Earnings ratio
—
Dividend yield
—
Average volume
79.17K
High today
$2.25
Low today
$2.13
Open price
$2.15
Volume
120.33K
52 Week high
$10.81
52 Week low
$2.13

MNOV News

Simply Wall St22h

Further weakness as MediciNova drops 12% this week, taking three-year losses to 76%

As an investor, mistakes are inevitable. But really big losses can really drag down an overall portfolio. So take a moment to sympathize with the long term shar

MNOV Earnings

-$0.09
-$0.06
-$0.03
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
Expected May 12, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure